1Takayanagi H,Kim S,Koga,T,et al.Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts[J].Dev Cell,2002,3(6):889-901.
2Koga T,Inui M,Inoue K,et al.Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis[J].Nature,2004,428(6984):758-763.
3Matsumoto M,Kogawa M,Wada S,et al.Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1[J].J Biol Chem,2004,279(44):45969-45979.
4Partington GA,Fuller K,Chambers TJ,et al.Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation[J].Bone,2004,34(2):237-245.
5Doffinger R,Smahi A,Bessia C,et al.X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling[J].Nat Genet,2001,27(3):277-285.
6Takayanagi H.Mechanistic insight into osteoclast differentiation in osteoimmunology[J].J Mol Med,2005,118(4):565-570.
3Onishi T,Ishidou Y,Nagamine T,et al.Distinct and overlapping patterns of localization of bone morphogenetic protein family members and a BMP typeⅡ receptor during fracture healing in rats.Bone,1998,22:605～612.
4Sailer HF,Kolb E.Application of purified bone morphogenetic protein(BMP) in cranio-maxillo-facial surgery,BMP incompr-onised surgical reconstruction using titanium implant.J Cran-iomuxillofac Sug,1994,22(1):2.
5刘忠厚.骨质疏松学.北京:北京科学出版社,1998,121-139.
6Yamada Y,Miyauchi A,Goto J,et al.Association of apolymorphi-sm of the transforming growth factor-beta gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women.J Bone Miner Res,1998,13(10):1569～1576.
7Kassem M,Kveiborg M,Eriksen EF.Production and action of transforming growth factor-beta in human osteoblast cultures:dependence on cell differentiation and modulation by calcitriol.Eur J Clin Invest,2000,30:429～437.
8Mehrara BJ,Saadeh PB,Steinbrech DS,et al.Adenovirus-mediated gene therapy of osteoblasts invitro and invivo.J Bone Miner Res,1999,14:1290～1301.
9Grainger DJ,Percival J,Chiano M,et al.The role of serum TGF-beta isoforms as potential markers of osteoporosis.Osteoporos Int,1999,9:398～404.
10Zerath E,Holy X,Noel B,et al.Effects of BMP-2 onosteoblastic cells and on skeletal growth and bone formation in unloaded rats.Growth Horm IGF Res,1998,8:141～149.
4Niilura K.vacuolar ATPase as a drug discovery. Drug News Perspect.2006; 19(3): 139-144.
5Cipriano DJ,Wang Y,Bond 5,et al.Structure and regulation of the vacuolar ATPase. Biochim Biophys Acta. 2008; 1777(7-8): 599-604.
6Lacey DL,Timms E,Tan HL,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell.2008;93(2): 165-176.
7Nordstron T, Shrode LD,Rotstein OD,et aI.Chronic extracellular acidosis induces plasmalemmal vacuolar type H^+ ATPase activity in osteoclasts.J Biol Chem.2007;272: 6354-6360.
8Beutler JA,McKee TC.Novel marine and microbial natural product inhibitors of vacuolar ATPase.Curr Med Chem. 2003 10(9):787-796.
9Zhao Q,Shao J,Chen W,et aI.Osteoclast differentiation and gene regulation. Front Biosci.2007; 12:2519-2529.
10Li YP, Chen W,Liang Y, et al. Atp6i deficient mice exhibit severe osteopetrosis due to loss of osteoclast-me-diated extracellular acidification.Nat genet.2009; 23(4):447-451.
